Vera Therapeutics (VERA) Prepaid Assets (2020 - 2026)
Vera Therapeutics' (VERA) quarterly Prepaid Assets came in at $2.5 million in Q1 2026, up 645.97% YoY from $335000.0 in Q1 2025, and down 82.52% on a QoQ basis from $14.3 million in Q4 2025.
Vera Therapeutics (VERA) Prepaid Assets (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 7 years of Prepaid Assets data on file, last reported at $2.5 million in Q1 2026.
- Quarterly Prepaid Assets rose 645.97% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 645.97% YoY) and the FY2025 annual result came in at $14.3 million, up 933.55% from the prior year.
- Prepaid Assets retreated to $2.5 million in Q1 2026, from $14.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $14.5 million in Q2 2025 to a low of $219000.0 in Q2 2022.
- A 5-year average of $4.0 million and a median of $905000.0 in 2023 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 5201.82% in 2025, down 97.36% in 2025.
- Tracing VERA's Prepaid Assets over 5 years: stood at $719000.0 in 2022, then dropped by 16.97% to $597000.0 in 2023, then jumped by 131.66% to $1.4 million in 2024, then soared by 933.55% to $14.3 million in 2025, then plunged by 82.52% to $2.5 million in 2026.
- The last three Prepaid Assets figures came in at $2.5 million (Q1 2026), $14.3 million (Q4 2025), and $969000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.33 Mn |
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 14.29 Mn |
| Sep 30, 2025 | 969,000.00 |
| Jun 30, 2025 | 14.53 Mn |
| Mar 31, 2025 | 335,000.00 |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 10.82 Mn |
| Jun 30, 2024 | 274,000.00 |
| Mar 31, 2024 | 12.71 Mn |
| Dec 31, 2023 | 597,000.00 |
| Sep 30, 2023 | 905,000.00 |
| Jun 30, 2023 | 251,000.00 |
| Mar 31, 2023 | 7.30 Mn |
| Dec 31, 2022 | 719,000.00 |
| Sep 30, 2022 | 241,000.00 |
| Jun 30, 2022 | 219,000.00 |
| Mar 31, 2022 | 759,000.00 |
| Dec 31, 2021 | 480,000.00 |
| Sep 30, 2021 | 3.57 Mn |